Viewing nowRosuvastatin Calcium 10 mg (Unclassified)
Rosuvastatin Calcium Micronized 10.4mg
Tablet · Prescription medication
Hanin Pharmaceutical Co., Ltd.

MFDS item code 201000989 · Approved 2010.01.28 · Insurance code 657202150
Treatment of dyslipidemia, inhibition of atherosclerosis progression, and prevention of cardiovascular disease
This medication is used as an adjunct for patients with primary hypercholesterolemia and mixed dyslipidemia who have difficulties in controlling their condition through diet and exercise. It lowers total cholesterol and LDL cholesterol levels in patients with hypercholesterolemia, effectively delaying the progression of atherosclerosis. Additionally, it is used as an adjunct in the treatment of patients with homozygous familial hypercholesterolemia and dysbetalipoproteinemia. It is also administered as an adjunct to diet in pediatric patients with heterozygous familial hypercholesterolemia that meet certain criteria. Furthermore, in adult patients with chronic cardiovascular risk factors, it is expected to reduce the risk of stroke, myocardial infarction, and vascular revascularization. Overall, this medication is used for the treatment of various types of dyslipidemia associated with hypercholesterolemia and for reducing the risk of cardiovascular diseases.
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), combined hyperlipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine, and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 mg once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to a maintenance dose. The maintenance dose is 10 mg once daily, which is sufficient to control the condition in most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer, according to LDL cholesterol levels, treatment goals, and patient response, and may be increased to a maximum of 20 mg daily. 3. Elderly patients : No dose adjustment is necessary. 4. Patients with renal impairment : No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering 20 mg of this medicine to patients with moderate renal impairment. 5. Patients with hepatic impairment : No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration in patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 6. Race : Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 mg. Administration of the 40 mg dose is contraindicated. 7. Patients predisposed to myopathy : The recommended initial dose for patients predisposed to myopathy is 5 mg. Administration of the 40 mg dose of this medicine is contraindicated in some of these patients.
Ages 10 to 17 years: The usual dose range is 5 mg to 20 mg once daily. (There are no clinical data on doses greater than 20 mg in pediatric patients.) The dose should be adjusted individually according to the recommended treatment goal for each patient. Dose adjustments should be made at intervals of 4 weeks or longer. Under 10 years of age: Safety and efficacy have not been established.
This medication should not be used in certain patients. For example, it must not be administered to patients allergic to the components of this medication, those with severely impaired liver function, patients with muscle diseases, and those with severe renal impairment. Women who are pregnant or breastfeeding, and fertile women who are not using appropriate contraception should not take this medication. Women with potential for pregnancy should only take this medication when it is highly unlikely that they are pregnant. Patients at high risk for myopathy or rhabdomyolysis, such as those with moderate or severe renal impairment, hypothyroidism, a personal history of genetic muscle diseases, alcoholism, or those taking certain other medications should be particularly cautious, and high doses are contraindicated. This medication contains lactose, so patients with genetic metabolic disorders such as lactose intolerance or galactose intolerance should not take it. Patients who consume alcohol excessively or have a history of liver disease should undergo liver function tests before taking this medication and should monitor liver function regularly during treatment. If symptoms such as muscle pain, muscle weakness, or cramps occur, they should immediately inform a physician, and necessary blood tests should be performed to check for muscle damage. If symptoms are severe or blood test results are elevated, the medication should be discontinued. This medication can cause liver function abnormalities, increase the risk of diabetes, and rarely lead to severe skin reactions or interstitial lung disease, so any unusual symptoms should be discussed with healthcare professionals immediately. Furthermore, there are many interactions with other medications, so if other medications are being taken, healthcare professionals should be informed, especially when taken with certain antiviral drugs, immunosuppressants, antibiotics, or fibrates. In case of overdose, as there is no specific antidote, the patient should visit the hospital immediately for appropriate treatment, and liver function and muscle enzyme levels should be closely monitored. Caution is advised as dizziness may occur while driving or operating machinery. Finally, this medication may show higher blood concentrations in Asians, so dose adjustment may be necessary.
Allergic reactions, angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, hives, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, ocular myasthenia, thrombocytopenia, jaundice, hepatitis, elevated transaminases, Stevens-Johnson syndrome, eosinophilia, drug reaction with eosinophilia and systemic symptoms syndrome, drug rash resembling erythema multiforme, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disturbances, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, numbness, paresthesia, chest discomfort, loss of appetite, abdominal distension, syncope, generalized pain, fatigue
Not everyone experiences these, and they can vary from person to person.
This medication must be stored in a tightly sealed container to prevent exposure to air or moisture. It is important to maintain a storage temperature between 1 degree Celsius and 30 degrees Celsius at room temperature to preserve the medication's effectiveness and safety.
Pink round film-coated tablets
30 tablets (10 tablets/PTP × 3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium Micronized 10.4mg
Tablet · Prescription medication
Hanin Pharmaceutical Co., Ltd.

Rosuvastatin Calcium Micronized 20.8mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

Rosuvastatin Calcium Micronized 5.2mg
Tablet · Prescription medication
Daiwoo Pharmaceutical Co., Ltd.

Rosuvastatin Calcium Micronized 10.4mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

Rosuvastatin Calcium Micronized 10.4mg
Tablet · Prescription medication
Myungjin Pharmaceutical Co., Ltd.

Rosuvastatin Calcium Micronized 5.2mg
Tablet · Prescription medication
Teragen Itex Co., Ltd.

Rosuvastatin Calcium Micronized 10.4mg
Tablet · Prescription medication
Teragen Etex Co., Ltd.

Rosuvastatin Calcium Micronized 20.8mg
Tablet · Prescription medication
TerraGen Etex Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.